CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

Other languages China Resources Double-Crane Pharmaceutical Co.,Ltd.

Equities

600062

CNE000000Q94

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 06/05/2024 am IST			5-day change	1st Jan Change
23.02 ^CNY	+5.74%		+8.58%	+23.76%

26/04	CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%	MT
26/04	CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%	26/04
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	26/04
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug	26/03
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets	12/03
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments	21/02
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient	08/02
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug	31/01
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs	14/12
CR Double-Crane Pharma Unit Gets Nod to Amend Sodium Lactate Ringer Injection's Details	12/12
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26
CR Double-Crane Pharma to Buy 90% Stake in Local Peer For 260 Million Yuan	28/23/28
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23
CR Double-Crane Pharma Gets Regulatory Nod to Amend Instructions for Lansoprazole for Injection	09/23/09
CR Double-Crane Pharma Units Get Regulatory Approvals in China	11/23/11
CR Double-Crane Pharma Unit Secures Registration Approval for Gout Drug in China	21/23/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China Resources Double-Crane Pharmaceutical Co.,Ltd.

Equities

600062

CNE000000Q94

Other languages

Filters